Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women.

Tseng HS, Lin C, Chan SE, Chien SY, Kuo SJ, Chen ST, Chang TW, Chen DR.

World J Surg Oncol. 2013 Jun 14;11:139. doi: 10.1186/1477-7819-11-139.

2.

Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.

Cao AY, He M, Liu ZB, Di GH, Wu J, Lu JS, Liu GY, Shen ZZ, Shao ZM.

Ann Surg Oncol. 2012 Sep;19(9):3019-27. doi: 10.1245/s10434-012-2322-6.

PMID:
22451233
4.

A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.

Di Saverio S, Gutierrez J, Avisar E.

Breast Cancer Res Treat. 2008 Oct;111(3):541-7.

PMID:
18026874
5.

Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified.

Park S, Koo J, Kim JH, Yang WI, Park BW, Lee KS.

J Korean Med Sci. 2010 Mar;25(3):361-8. doi: 10.3346/jkms.2010.25.3.361.

6.

Clinicopathological characteristics and prognosis of mucinous breast carcinoma.

Zhang M, Teng XD, Guo XX, Zhao JS, Li ZG.

J Cancer Res Clin Oncol. 2014 Feb;140(2):265-9. doi: 10.1007/s00432-013-1559-1.

PMID:
24305754
7.

Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.

Gokce H, Durak MG, Akin MM, Canda T, Balci P, Ellidokuz H, Demirkan B, Gorken IB, Sevinc AI, Kocdor MA, Saydam S, Harmancioglu O.

Breast J. 2013 Jul-Aug;19(4):374-81. doi: 10.1111/tbj.12128.

PMID:
23714006
8.

Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.

Yan J, Liu XL, Han LZ, Xiao G, Li NL, Deng YN, Yin LC, Ling LJ, Yu XY, Tan CL, Huang XP, Liu LX.

Asian Pac J Cancer Prev. 2015;16(2):823-9.

9.

Male breast cancers behave differently in elderly patients.

Tural D, Selçukbiricik F, Aydoğan F, Beşe N, Yetmen O, Ilvan Ş, Büyükünal E, Serdengeçti S.

Jpn J Clin Oncol. 2013 Jan;43(1):22-7. doi: 10.1093/jjco/hys193.

10.

Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.

Song Y, Liu X, Zhang G, Song H, Ren Y, He X, Wang Y, Zhang J, Zhang Y, Sun S, Liang X, Sun Q, Pang D.

World J Surg Oncol. 2013 Jun 6;11:129. doi: 10.1186/1477-7819-11-129.

11.

The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients.

Bae SY, Lee SK, Koo MY, Hur SM, Choi MY, Cho DH, Kim S, Choe JH, Lee JE, Kim JH, Kim JS, Nam SJ, Yang JH.

Breast Cancer Res Treat. 2011 Apr;126(2):471-8. doi: 10.1007/s10549-011-1359-8.

PMID:
21287362
12.

Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.

Hussein MR, Abd-Elwahed SR, Abdulwahed AR.

Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007.

PMID:
18296077
13.

The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.

Lai HW, Tseng LM, Chang TW, Kuo YL, Hsieh CM, Chen ST, Kuo SJ, Su CC, Chen DR.

Breast. 2013 Oct;22(5):968-73. doi: 10.1016/j.breast.2013.05.010.

PMID:
23787124
14.

Do clinical and immunohistochemical findings of pure mucinous breast carcinoma differ from mixed mucinous breast carcinoma?

Erhan Y, Ciris M, Zekioglu O, Erhan Y, Kapkac M, Makay O, Ozdemir N.

Acta Chir Belg. 2009 Mar-Apr;109(2):204-8.

PMID:
19499682
15.

Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.

Thurman SA, Schnitt SJ, Connolly JL, Gelman R, Silver B, Harris JR, Recht A.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):152-9.

PMID:
15093911
16.

Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs.

Demir L, Yigit S, Ellidokuz H, Erten C, Somali I, Kucukzeybek Y, Alacacioglu A, Cokmert S, Can A, Akyol M, Dirican A, Bayoglu V, Sari AA, Tarhan MO.

Clin Exp Metastasis. 2013 Dec;30(8):1047-62. doi: 10.1007/s10585-013-9602-9.

PMID:
23836289
17.

Clinicopathologic characteristics and prognosis for molecular subtypes in low-grade breast carcinoma: comparison with grade one invasive ductal carcinoma-not otherwise specified.

Wang S, Li W, Liu N, Zhang T, Liu H, Liu J, Liu F, Zhang W, Gebreamlak EP, Niu Y.

Med Oncol. 2012 Dec;29(4):2556-64. doi: 10.1007/s12032-012-0174-3.

PMID:
22311262
18.

[Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].

Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH.

Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):520-5. Chinese.

PMID:
21029696
19.

Invasive cribriform carcinoma in a Chinese population: comparison with low-grade invasive ductal carcinoma-not otherwise specified.

Zhang W, Zhang T, Lin Z, Zhang X, Liu F, Wang Y, Liu H, Yang Y, Niu Y.

Int J Clin Exp Pathol. 2013;6(3):445-57.

20.

Predictors of early distant metastasis in women with breast cancer.

Rosa Mendoza ES, Moreno E, Caguioa PB.

J Cancer Res Clin Oncol. 2013 Apr;139(4):645-52. doi: 10.1007/s00432-012-1367-z.

PMID:
23283528
Items per page

Supplemental Content

Support Center